EGFR inhibitors

The present disclosure provides a compound represented by structural formula (I-0): or a pharmaceutically acceptable salt thereof useful for treating a cancer.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CAMPBELL, JOHN EMMERSON, ENO, MEREDITH SUZANNE, DINEEN, THOMAS A, AHMAD, OMAR, FERNANDO, DILINIE PRASADHINI
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure provides a compound represented by structural formula (I-0): or a pharmaceutically acceptable salt thereof useful for treating a cancer.